FDA approves new obesity drug Zepbound from Eli Lilly

Zepbound, with the same active ingredient as Mounjaro, was approved by the FDA this week. The approval allows for more access to the new drug, which targets feelings of fullness for weight-loss goals.

WATCH the ABC News Live Stream Here:
https://www.youtube.com/watch?v=w_Ma8oQLmSM
SUBSCRIBE to ABC NEWS: https://bit.ly/2vZb6yP
Watch More on http://abcnews.go.com/
LIKE ABC News on FACEBOOK https://www.facebook.com/abcnews
FOLLOW ABC News on TWITTER: https://twitter.com/abc

#fda #zepbound #mounjaro #weightloss #abcnl #abcnews

Видео FDA approves new obesity drug Zepbound from Eli Lilly канала ABC News